Status:
UNKNOWN
Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder
Lead Sponsor:
China Medical University Hospital
Conditions:
Wu-Chu-Yu Tang
Gastroesophageal Reflux Disorder
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
Gastroesophageal reflux disorder (GERD) is due to gastric content reflux to esophagus cause symptom and complication including intra-esophagus such as reflux esophagitis, and extra-esophagus such as c...
Eligibility Criteria
Inclusion
- Gender：male or female.
- Age：from 20 years old (inclusive) to 75 years old (inclusive).
- Diagnosis of gastroesophageal reflux disease.
- there is a heartburn or acid regurgitation phenomenon.
- After detailed description of the entire research purpose or process, voluntarily participate in the study and sign the consent form.
Exclusion
- Exclude peptic ulcers, gallstones (including intrahepatic and common bile ducts) and major diseases such as: cancer, congestive hear failured NYHA class\>II, COPD attack.
- Barrett's esophagus, narrow esophagus or caustic injury of upper gastrointestinal tract.
- History of esophagus and gastroduodenal surgery.
- Tarry stool suspected gastrointestinal bleeding.
- History of alcohol or drug abuse.
- Patients with a history of allergies to the test drug.
- Can not cooperate with mental illness.
- Pregnant women or women who are breastfeeding.
- Liver function SGOT and SGPT are more than twice the normal value.
- renal function test BUN, Creatinine is greater than the normal value.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04118647
Start Date
October 1 2019
End Date
September 1 2021
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, North District, Taiwan, 40447